New spinal implant for kids with scoliosis under Long-Term safety review
NCT ID NCT07403084
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 140 children aged 5 to 17 with progressive scoliosis who receive the NEMOST V2 growing domino implant. The implant is designed to straighten the spine as the child grows. Researchers will monitor complications and how well the device works over 5 years after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NEMOST V2 growing domino (spinal implant)
What this could lead to
If successful, this could confirm that the NEMOST implant is a safe and effective way to correct progressive scoliosis in growing children, reducing the need for repeated surgeries.
What could go wrong
This is an observational post-market study, not a randomized trial, so results may not prove the device is better than other treatments. Complications like infection or implant failure are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCOLIOSIS IDIOPATHIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Pellegrin
RECRUITINGBordeaux, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Hopital Armand Trousseau
NOT_YET_RECRUITINGParis, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hopital Lenval Nice
RECRUITINGNice, Provence-Alpes-Côte d'Azur Region, 06000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hopital Necker
NOT_YET_RECRUITINGParis, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospices Civils de Lyon
NOT_YET_RECRUITINGLyon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact